1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.
(
- Contribution to journal › Article
- 2014
-
Mark
Cabozantinib Resolves Bone Scans in Tumor-Naive Mice Harboring Skeletal Injuries
(
- Contribution to journal › Article
-
Mark
Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Organoid cultures derived from patients with advanced prostate cancer
(
- Contribution to journal › Article